TFF Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-12.675; its P/E ratio is -0.48; TFF Pharmaceuticals is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-1.92. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	$ 333.35K	$ 51.43K	$ 312.78K	$ 0.00	$ 0.00
Gross Profit	$ 333.35K	$ 51.43K	$ 207.35K	-	-
EBIT	$ -5.06M	$ 7.21M	$ -7.54M	$ -7.28M	$ -8.77M
EBITDA	-	$ 7.33M	$ -7.42M	$ -7.18M	$ -8.68M
Net Income Common Stockholders	$ -5.02M	$ 191.69K	$ -71.05K	$ -7.27M	$ -8.75M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 7.66M	$ 12.22M	$ 16.61M	$ 13.15M	$ 20.89M
Total Assets	$ 13.57M	$ 18.21M	$ 24.12M	$ 20.23M	$ 27.91M
Total Debt	$ 154.27K	$ 172.94K	$ 190.72K	$ 208.15K	$ 225.24K
Net Debt	$ -7.51M	$ -12.04M	$ -16.42M	$ -12.94M	$ -20.67M
Total Liabilities	$ 1.29M	$ 1.67M	$ 1.24M	$ 2.20M	$ 3.97M
Stockholders Equity	$ 12.28M	$ 16.54M	$ 22.88M	$ 18.02M	$ 23.94M
Cash Flow	-
Free Cash Flow	-	$ -4.34M	$ -9.25M	$ -8.16M	$ -5.51M
Operating Cash Flow	$ -4.46M	$ -4.34M	$ -7.70M	$ -7.38M	$ -5.01M
Investing Cash Flow	$ -35.71K	-	$ -141.17K	$ -777.48K	$ -495.45K
Financing Cash Flow	$ -59.23K	$ -44.64K	$ 11.34M	$ 430.74K	$ -15.99K

Currency in USD

TFF Pharmaceuticals Earnings and Revenue History

Income Statement >

TFF Pharmaceuticals Debt to Assets

Balance Sheet >

TFF Pharmaceuticals Cash Flow

Cash Flow >

TFF Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing